INmune Bio, Inc.

NASDAQ:INMB

5.72 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q12016 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 33.55231.06926.00235.84841.81347.82551.00352.15357.40561.21366.72974.8184.47139.5245.3421.96724.3114.8175.9316.9967.3839.3646.0490.1860.6511.1081.9561.3711.843-0.1420.142
Short Term Investments 000000000000000000000000000000.2830
Cash and Short Term Investments 33.55231.06926.00235.84841.81347.82551.00352.15357.40561.21366.72974.8184.47139.5245.3421.96724.3114.8175.9316.9967.3839.3646.0490.1860.6511.1081.9561.3711.8430.1420.142
Net Receivables 03.4132.692.4422.26302.218.4614.5315.065.6485.5045.1463.1192.3441.7991.6091.20.7840.6451.060.9980.8060.6480.354000.328000
Inventory -1.4200000.030.0350.034000-5.5040000000000000000000
Other Current Assets 0.8791.0131.1321.6521.5352.7373.6684.0614.7224.2734.6822.2921.3141.411.5290.220.2170.3420.2660.1240.2410.4450.2760.0160.1590.4030.3590.0430.27100.31
Total Current Assets 35.85135.49529.82439.94245.61152.60856.88164.67566.65870.54677.05982.60690.93144.04949.21323.98626.1376.3596.9817.7658.68310.8077.1310.8491.1641.7162.3161.8992.1140.1420.452
Non-Current Assets:
Property, Plant & Equipment, Net 0.3350.3630.3890.4140.4440.4680.4850.5070.5290.650.6810.7260.1280.1370.1470.1560.1650.1750.1830.1920.1990.209000000000
Goodwill 0000000000000000000000000000000
Intangible Assets 16.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.514000
Goodwill and Intangible Assets 16.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.51416.514000
Long Term Investments 0000000000000000000000000000000
Tax Assets 0000000000000000000000000000000
Other Non-Current Assets 0.0820.0810.1060.1310.1290.130.0990.0990.0990.0990.0990.0990.0990000000000000000-0.1420
Total Non-Current Assets 16.93116.95817.00917.05917.08717.11217.09817.1217.14217.26317.29417.33916.74116.65116.66116.6716.67916.68916.69716.70616.71316.72316.51416.51416.51416.51416.51416.5140-0.1420
Total Assets 52.78252.45346.83357.00162.69869.7273.97981.79583.887.80994.35399.945107.67260.765.87440.65642.81623.04823.67824.4725.39627.5323.64517.36317.67818.2318.8318.4132.11400.452
Liabilities & Equity:
Current Liabilities:
Account Payables 10.6459.2829.2947.9013.6752.3852.0775.2153.4651.6872.5513.8134.2212.3611.5721.5181.1910.6250.6960.4020.3370.4380.4810.5530.2020.1580.1960.1360.10100.221
Short Term Debt 2.6295.2397.5810.15910.21210.2027.7125.1742.7880.2260.1640.1440.0760.0720.0460.0340.040.0140.0370.0080.0320.015000000000.35
Tax Payables 0000000000000000000000000000000
Deferred Revenue 0.5490.5210.520.4890.4960.560.5910.6160.7780.4760.584-3.6690.5410.5830.5910-1.191-0.6250.3-0.298-0.337-0.5080.300000000
Other Current Liabilities 00.530.0560.4050.4690.4680.4940.5290.6420.3720.5110.4020.5130.5560.5780.2240.2430.578-0.1310.290.1460.06200.2710.0090.03700.1730.09100.03
Total Current Liabilities 13.82315.05117.4518.46514.35613.05510.28310.9186.8952.2853.2264.3594.812.9892.1961.7761.4741.2171.1170.70.5160.5160.7810.8240.2110.1950.1960.310.19200.601
Non-Current Liabilities:
Long Term Debt 0.5680.3220.360.3972.8065.2857.76210.22312.73615.21615.19815.16214.49614.4540.1160.1260.1360.1450.1540.160.1720.177000000000
Deferred Revenue Non-Current 0000000000000000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000000000000000
Other Non-Current Liabilities -0.2840000.8040.7260.6380.550.4630.3750.2870.1990.1110.02400000000000000000
Total Non-Current Liabilities 0.2840.3220.360.3973.616.0118.410.77313.19915.59115.48515.36114.60714.4780.1160.1260.1360.1450.1540.160.1720.177000000000
Total Liabilities 14.10715.37317.8118.86217.96619.06618.68321.69120.09417.87618.71119.7219.41717.4672.3121.9031.611.3631.2710.8610.6870.6930.7810.8240.2110.1950.1960.310.19200.601
Equity:
Preferred Stock 00.7990.7990.7990.78100000000000000000000000000
Common Stock 0.0220.8190.8170.8170.8170.0180.0180.0180.0180.0180.0180.0180.0180.0150.0150.0130.0130.0110.0110.0110.0110.0110.010.0090.0090.0090.0090.0080.00700.005
Retained Earnings -153.886-141.793-132.047-121.022-112.614-104.051-97.55-91.014-85.181-77.456-70.618-63.715-54.044-44.586-37.931-33.375-30.171-25.454-23.347-21.276-18.958-15.891-15.499-13.598-11.718-10.178-4.004-1.158-0.730-0.326
Accumulated Other Comprehensive Income/Loss -1.036-0.713-0.669-0.799-0.735-0.712-0.708-0.699-1.142-0.7010.0560.001-0.118-0.050.0120.011-0.0380.01-0.029-0.009-0.055-0.0190.0060.0070.0094.6920.0960.0320.029-0.1490.047
Other Total Stockholders Equity 193.575178.767160.922159.143157.264155.399153.536151.799150.011148.072146.186143.921142.39987.854101.46672.10471.40247.11845.77244.83443.71142.73738.34725.44624.49123.51222.53219.1712.56600.125
Total Shareholders Equity 38.67537.0829.02338.13944.73250.65455.29660.10463.70669.93375.64280.22588.25543.23363.56238.75341.20621.68522.40723.6124.70926.83722.86416.5417.46718.03518.63318.1041.873-0.149-0.149
Total Equity 38.67537.0829.02338.13944.73250.65455.29660.10463.70669.93375.64280.22588.25543.23363.56238.75341.20621.68522.40723.6124.70926.83722.86416.5417.46718.03518.63318.1041.873-0.149-0.149
Total Liabilities & Shareholders Equity 52.78252.45346.83357.00162.69869.7273.97981.79583.887.80994.35399.945107.67260.765.87440.65642.81623.04823.67824.4725.39627.5323.64517.36317.67818.2318.8318.4132.064-0.1490.452